A prospective study found that low levels of VEGF-C could independently predict all-cause mortality in patients with suspected or confirmed coronary artery disease (CAD) (87), while high levels of VEGF-C could degrade inflammation after MI, which was beneficial to the repair of injured myocardium (88). This evidence concerns the gene VEGFC and coronary artery disorder.